Weight-loss Drugs May Offer Disease Protection

Research suggests that GLP-1 medications, such as Ozempic and Wegovy, may be associated with a lower risk of breast cancer recurrence and potential prevention. The drugs' benefits are thought to stem from weight loss and reduced inflammation, which improve prognosis, particularly in post-menopausal women. However, current evidence is observational, and further research is needed to confirm a direct causal effect.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article